These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34432301)

  • 21. The effect of scoliosis surgery on pulmonary function in spinal muscular atrophy type II patients.
    Chou SH; Lin GT; Shen PC; Lue YJ; Lu CC; Tien YC; Lu YM
    Eur Spine J; 2017 Jun; 26(6):1721-1731. PubMed ID: 27807779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risdiplam in non-sitter patients aged 16 years and older with 5q spinal muscular atrophy.
    Ñungo Garzón NC; Pitarch Castellano I; Sevilla T; Vázquez-Costa JF
    Muscle Nerve; 2023 May; 67(5):407-411. PubMed ID: 36815750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality of life assessment in adult spinal muscular atrophy patients treated with nusinersen.
    Bonanno S; Zanin R; Bello L; Tramacere I; Bozzoni V; Caumo L; Ferraro M; Bortolani S; Sorarù G; Silvestrini M; Vacchiano V; Turri M; Tanel R; Liguori R; Coccia M; Mantegazza RE; Mongini T; Pegoraro E; Maggi L
    J Neurol; 2022 Jun; 269(6):3264-3275. PubMed ID: 34978620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spinal muscular atrophy: survival pattern and functional status.
    Chung BH; Wong VC; Ip P
    Pediatrics; 2004 Nov; 114(5):e548-53. PubMed ID: 15492357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing perspectives of disease burden and clinically meaningful changes using the Spinal Muscular Atrophy Health Index in adolescents and young adults.
    Mazzella A; Cruz R; Belter L; Curry M; Dilek N; Zizzi C; Heatwole C; Jarecki J
    Muscle Nerve; 2022 Sep; 66(3):276-281. PubMed ID: 35616549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age related treatment effect in type II Spinal Muscular Atrophy pediatric patients treated with nusinersen.
    Coratti G; Pane M; Lucibello S; Pera MC; Pasternak A; Montes J; Sansone VA; Duong T; Dunaway Young S; Messina S; D'Amico A; Civitello M; Glanzman AM; Bruno C; Salmin F; Tacchetti P; Carnicella S; Sframeli M; Antonaci L; Frongia AL; De Vivo DC; Darras BT; Day J; Bertini E; Muntoni F; Finkel R; Mercuri E;
    Neuromuscul Disord; 2021 Jul; 31(7):596-602. PubMed ID: 34099377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upper limb module in non-ambulant patients with spinal muscular atrophy: 12 month changes.
    Sivo S; Mazzone E; Antonaci L; De Sanctis R; Fanelli L; Palermo C; Montes J; Pane M; Mercuri E
    Neuromuscul Disord; 2015 Mar; 25(3):212-5. PubMed ID: 25500010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical features of spinal muscular atrophy (SMA) type 3 (Kugelberg-Welander disease).
    Salort-Campana E; Quijano-Roy S
    Arch Pediatr; 2020 Dec; 27(7S):7S23-7S28. PubMed ID: 33357593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Responsiveness of the motor function measure in patients with spinal muscular atrophy.
    Vuillerot C; Payan C; Iwaz J; Ecochard R; Bérard C;
    Arch Phys Med Rehabil; 2013 Aug; 94(8):1555-61. PubMed ID: 23380348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug treatment for spinal muscular atrophy types II and III.
    Wadman RI; van der Pol WL; Bosboom WM; Asselman FL; van den Berg LH; Iannaccone ST; Vrancken AF
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD006282. PubMed ID: 32006461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Scoliosis in spinal muscular atrophy: review of 63 cases.
    Rodillo E; Marini ML; Heckmatt JZ; Dubowitz V
    J Child Neurol; 1989 Apr; 4(2):118-23. PubMed ID: 2785548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sometimes they come back: New and old spinal muscular atrophy adults in the era of nusinersen.
    Sansone VA; Coratti G; Pera MC; Pane M; Messina S; Salmin F; Albamonte E; De Sanctis R; Sframeli M; Di Bella V; Morando S; d'Amico A; Frongia AL; Antonaci L; Pirola A; Pedemonte M; Bertini E; Bruno C; Mercuri E;
    Eur J Neurol; 2021 Feb; 28(2):602-608. PubMed ID: 33012052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Somatropin treatment of spinal muscular atrophy: a placebo-controlled, double-blind crossover pilot study.
    Kirschner J; Schorling D; Hauschke D; Rensing-Zimmermann C; Wein U; Grieben U; Schottmann G; Schara U; Konrad K; Müller-Felber W; Thiele S; Wilichowski E; Hobbiebrunken E; Stettner GM; Korinthenberg R
    Neuromuscul Disord; 2014 Feb; 24(2):134-42. PubMed ID: 24300782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Characteristics in the treatment of scoliosis in muscular diseases].
    Forst R; Forst J; Heller KD; Hengstler K
    Z Orthop Ihre Grenzgeb; 1997; 135(2):95-105. PubMed ID: 9214180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minimal clinically important differences in functional motor scores in adults with spinal muscular atrophy.
    Stolte B; Bois JM; Bolz S; Kizina K; Totzeck A; Schlag M; Kleinschnitz C; Hagenacker T
    Eur J Neurol; 2020 Dec; 27(12):2586-2594. PubMed ID: 32781490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of nusinersen in type 1, 2 and 3 spinal muscular atrophy: Real world data from Hungarian patients.
    Szabó L; Gergely A; Jakus R; Fogarasi A; Grosz Z; Molnár MJ; Andor I; Schulcz O; Goschler Á; Medveczky E; Czövek D; Herczegfalvi Á
    Eur J Paediatr Neurol; 2020 Jul; 27():37-42. PubMed ID: 32456992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An observational cohort study on pulmonary function in adult patients with 5q-spinal muscular atrophy under nusinersen therapy.
    Bjelica B; Wohnrade C; Osmanovic A; Schreiber-Katz O; Petri S
    J Neurol; 2023 Jul; 270(7):3616-3622. PubMed ID: 37062018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nusinersen for Spinal Muscular Atrophy in the United States: Findings From a Retrospective Claims Database Analysis.
    Gauthier-Loiselle M; Cloutier M; Toro W; Patel A; Shi S; Davidson M; Bischof M; LaMarca N; Dabbous O
    Adv Ther; 2021 Dec; 38(12):5809-5828. PubMed ID: 34713391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Muscle quantitative MRI in adult SMA patients on nusinersen treatment: a longitudinal study.
    Gallone A; Mazzi F; Bonanno S; Zanin R; Moscatelli M; Aquino D; Maggi L
    Acta Myol; 2022 Jun; 41(2):76-83. PubMed ID: 35832502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upper limb evaluation and one-year follow up of non-ambulant patients with spinal muscular atrophy: an observational multicenter trial.
    Seferian AM; Moraux A; Canal A; Decostre V; Diebate O; Le Moing AG; Gidaro T; Deconinck N; Van Parys F; Vereecke W; Wittevrongel S; Annoussamy M; Mayer M; Maincent K; Cuisset JM; Tiffreau V; Denis S; Jousten V; Quijano-Roy S; Voit T; Hogrel JY; Servais L
    PLoS One; 2015; 10(4):e0121799. PubMed ID: 25861036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.